Symphony Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,653	Closed	-$215K	–	195
2018 Q2	$215K	Sell	2,653 -2,483	-48%	-$217K	0.04%	221
2018 Q1	$417K	Sell	5,136 -1,314	-20%	-$113K	0.05%	264
2017 Q4	$575K	Sell	6,450 -144	-2%	-$12.5K	0.06%	239
2017 Q3	$614K	Buy	6,594 +129	+2%	+$11.4K	0.07%	238
2017 Q2	$587K	Buy	6,465 +73	+1%	+$6.64K	0.07%	248
2017 Q1	$561K	Buy	6,392 +1,849	+41%	+$164K	0.05%	267
2016 Q4	$377K	Sell	4,543 -915	-17%	-$78.7K	0.04%	328
2016 Q3	$505K	Sell	5,458 -117	-2%	-$11K	0.05%	267
2016 Q2	$434K	Sell	5,575 -190	-3%	-$16.2K	0.05%	253
2016 Q1	$476K	Buy	+5,765	New	+$469K	0.05%	256
2014 Q2	–	Sell	-4,414	Closed	-$301K	–	408
2014 Q1	$301K	Buy	4,414 +385	+10%	+$28.4K	0.03%	379
2013 Q4	$283K	Buy	+4,029	New	+$274K	0.02%	390